Diaverum enters UAE as global investment in renal care surges

Multinational dialysis provider Diaverum is set to begin operations in the UAE. This expansion follows Diaverum’s acquisition by M42, an Abu Dhabi-based provider focused on AI-driven, technology-enabled healthcare, backed by global asset management firm Mubadala. 

Diaverum enters Greece, and plans expansion

Multinational dialysis giant Diaverum has entered the Greek market with the acquisition of six clinics. HBI hears the group has plans to consolidate more of the market and become the country’s best quality provider.

Mubadala-backed M42 buying Diaverum “for $2bn+”

Swedish multinational dialysis firm Diaverum is being bought by M42, a joint venture between Abu Dhabi sovereign wealth fund Mubadala Investment Co and AI firm G42, for a reported $2bn-$2.5bn. Diaverum’s CEO tells HBI the deal offers further opportunities to develop its digital strategies, and international expansion. 

Interview: Mark Hellowell, Lecturer, University of Edinburgh

Hellowell is a healthcare academic who specialises in PPPs, evaluating their performance around the world, consulting with development agencies and acting as a special adviser to the Health Select Committee in the British House of Commons. He also lectures on healthcare reform to a diverse group of postgraduate students, many of them from developing countries. We talk to him about the role private healthcare companies can, and are, playing in the developing and developed worlds, the future for PPPs, and whether they are “a good thing”.

Canada Pension Plan Investment Board backs Orpea’s international expansion

One of the world’s top 20 investors, with nearly C$200bn under management, has invested €321m for a 15% stake in French nursing home group Orpea, bought from company founder Jean-Claude Marian. The Canada Pension Plan Investment Board (CPPIB) says that it has bought into Orpea on the strength of its international expansion plans. The CPPIB also underwrote and bought 30% of a share issue to finance new growth. We look at CPPIB’s strategy, the state of play in the nursing home sector, and talk to Scott Lawrence, Vice President & Head of Relationship Investments at CPPIB.

Interview: Dag Andersson, CEO, Diaverum

With close to 300 dialysis centres in 19 countries, Diaverum's Dag Andersson claims to run “the most global healthcare service in the world”. The company is majority-owned by private equity house Bridgepoint, which hired JP Morgan in January 2013 to review the company's strategic options. We speak to Andersson about Diaverum's future.

Baxter swoops on Gambro

As predicted here, Baxter - the world’s largest peritoneal dialysis operator - has purchased Gambro, the second-largest player in haemodialysis in Europe, for SEK 26.5bn (€3.08bn) from EQT and Investor. The deal is seen as a way for Baxter to present itself as a "one-stop shop" to payors and providers, and to better compete with Fresenius, the world’s largest player in dialysis.

All change in dialysis

The dialysis sector looks certain to consolidate fast in Europe. Bankers say that Bridgepoint is keen to exit Diaverum, which it bought near the height of the boom in late 2007. Meanwhile, they also say that Baxter looks near certain to buy EQT-backed Gambro.

New homecare model goes international

Buurtzorg, the largest and fastest-growing homecare company in the Netherlands, is expanding into Sweden, with plans for further moves across Europe. Sales will come to €130m in 2011 up from €80m in 2010. Its model, based on giving nurses the power to manage each branch as if it were their own business, is backed by a powerful IT system linked into the public sector system. We talk to majority owner Edwin Oude Middendorp....

DaVita plans European expansion

DaVita, the US player which is the world's second largest dialysis company, has hired Bjorn Englund, the former head of Euromedic's dialysis unit which was sold this year to world number one Fresenius. We talk to Englund about his plans.  ...